Logo image of USER

USERTESTING INC (USER) Stock Fundamental Analysis

NYSE:USER - New York Stock Exchange, Inc. - US91734E1010 - Common Stock - Currency: USD

7.5  -0.01 (-0.13%)

After market: 7.5 0 (0%)

Fundamental Rating

3

Overall USER gets a fundamental rating of 3 out of 10. We evaluated USER against 282 industry peers in the Software industry. The financial health of USER is average, but there are quite some concerns on its profitability. While showing a medium growth rate, USER is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year USER has reported negative net income.
USER had a negative operating cash flow in the past year.
USER Yearly Net Income VS EBIT VS OCF VS FCFUSER Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 -10M -20M -30M -40M -50M

1.2 Ratios

The profitability ratios for USER are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
USER Yearly ROA, ROE, ROICUSER Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 50 -50 100 150 200

1.3 Margins

USER has a better Gross Margin (77.66%) than 77.15% of its industry peers.
The Profit Margin and Operating Margin are not available for USER so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
USER Yearly Profit, Operating, Gross MarginsUSER Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 0 20 -20 40 60

6

2. Health

2.1 Basic Checks

USER does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for USER has been increased compared to 1 year ago.
USER has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
USER Yearly Shares OutstandingUSER Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 50M 100M
USER Yearly Total Debt VS Total AssetsUSER Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 50M 100M 150M 200M 250M

2.2 Solvency

USER has an Altman-Z score of 4.13. This indicates that USER is financially healthy and has little risk of bankruptcy at the moment.
USER's Altman-Z score of 4.13 is fine compared to the rest of the industry. USER outperforms 70.53% of its industry peers.
USER has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.13
ROIC/WACCN/A
WACC10.36%
USER Yearly LT Debt VS Equity VS FCFUSER Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.86 indicates that USER should not have too much problems paying its short term obligations.
The Current ratio of USER (1.86) is comparable to the rest of the industry.
A Quick Ratio of 1.86 indicates that USER should not have too much problems paying its short term obligations.
USER has a Quick ratio (1.86) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.86
USER Yearly Current Assets VS Current LiabilitesUSER Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 50M 100M 150M 200M

4

3. Growth

3.1 Past

USER shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -56.10%.
Looking at the last year, USER shows a very strong growth in Revenue. The Revenue has grown by 37.98%.
EPS 1Y (TTM)-56.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.98%
Revenue 1Y (TTM)37.98%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%27.85%

3.2 Future

The Earnings Per Share is expected to grow by 12.27% on average over the next years. This is quite good.
Based on estimates for the next years, USER will show a very strong growth in Revenue. The Revenue will grow by 20.44% on average per year.
EPS Next Y77.79%
EPS Next 2Y33.98%
EPS Next 3Y21.75%
EPS Next 5Y12.27%
Revenue Next Year33.37%
Revenue Next 2Y26.6%
Revenue Next 3Y26.5%
Revenue Next 5Y20.44%

3.3 Evolution

USER Yearly Revenue VS EstimatesUSER Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
USER Yearly EPS VS EstimatesUSER Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for USER. In the last year negative earnings were reported.
Also next year USER is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
USER Price Earnings VS Forward Price EarningsUSER Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USER Per share dataUSER EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as USER's earnings are expected to grow with 21.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.98%
EPS Next 3Y21.75%

0

5. Dividend

5.1 Amount

USER does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

USERTESTING INC

NYSE:USER (1/11/2023, 8:04:01 PM)

After market: 7.5 0 (0%)

7.5

-0.01 (-0.13%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-27 2022-10-27/bmo
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.08B
Analysts52.86
Price Target7.65 (2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)44.32%
Min EPS beat(2)31.37%
Max EPS beat(2)57.27%
EPS beat(4)4
Avg EPS beat(4)37.7%
Min EPS beat(4)26.56%
Max EPS beat(4)57.27%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.01%
Min Revenue beat(2)-0.93%
Max Revenue beat(2)0.9%
Revenue beat(4)3
Avg Revenue beat(4)2.47%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)6.76%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.78%
PT rev (3m)N/A
EPS NQ rev (1m)-0.91%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.85
P/FCF N/A
P/OCF N/A
P/B 8.51
P/tB 9.17
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS1.28
BVpS0.88
TBVpS0.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.66%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 61.02%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.86
Altman-Z 4.13
F-Score4
WACC10.36%
ROIC/WACCN/A
Cap/Depr(3y)157.11%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.98%
EPS Next Y77.79%
EPS Next 2Y33.98%
EPS Next 3Y21.75%
EPS Next 5Y12.27%
Revenue 1Y (TTM)37.98%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%27.85%
Revenue Next Year33.37%
Revenue Next 2Y26.6%
Revenue Next 3Y26.5%
Revenue Next 5Y20.44%
EBIT growth 1Y-50.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year21.45%
EBIT Next 3Y6.38%
EBIT Next 5Y2.99%
FCF growth 1Y-183.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-187.16%
OCF growth 3YN/A
OCF growth 5YN/A